Veeva Systems Inc. (VEEV)

NYSE · Health Care · Health Information Services
By Alex · Tickerpine
$241.51
+4.93 (+2.08%)
Price — last 10 years monthly, dividend-adjusted · hover for detail
Market Cap
$39.23B
P/E (TTM)
42.0
Forward P/E
24.1
EPS (TTM)
$5.75
ROE
13.93%
Profit Margin
28.37%
Revenue Growth
16.30%
Dividend Yield
Beta
0.92
52W High
$310.50
52W Low
$148.05
Analyst Target
$244.14

VEEV stock forecast: what analysts expect

Consensus rating
Buy
Avg. 12-month target
$244.14
Implied upside
+1.1%

Wall Street analysts covering Veeva Systems Inc. currently rate the stock a Buy on average, with a mean 12-month price target of $244.14 — +1.1% versus the last price of $241.51. Targets reflect analyst opinion, not a guarantee.

What would an investment in VEEV be worth today?
Run VEEV through our free historical return calculator.
Calculate VEEV returns →

VEEV historical returns

PeriodTotal returnAnnualized (CAGR)$1,000 grew to
1 year -10.3% -10.3% $897
3 years +15.7% +5.0% $1,157
5 years -27.3% -6.2% $727
10 years +490% +19.4% $5,902
Since 2013 +521% +15.3% $6,207

Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in VEEV.

VEEV annual returns by year

2026 YTD +8.2%
2025 +6.2%
2024 +9.2%
2023 +19.3%
2022 -36.8%
2021 -6.2%
2020 +93.6%
2019 +57.5%
2018 +61.6%
2017 +35.8%

Congress trading in VEEV

6 members of Congress have disclosed trading VEEV — 3 purchases and 5 sales worth an estimated $231,000. Most recent disclosure: May 16, 2025.

Insider activity in VEEV

VEEV's own executives and directors have made 0 open-market purchases ($0) and 1 sale ($1.0M) in the last 90 days, per SEC Form 4 filings. Most recent: Jul 16, 2026.

Jul 16, 2026Schwenger Thomas D. Pres. & Chief Customer Officer Sell $1.0M

About Veeva Systems Inc.

Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics. In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services. Further, it provides professional and support services, including implementation and deployment planning, and project management; requirements analysis, solution design, and configuration; systems environment management and deployment; services focused on advancing or transforming business and operating processes; technical consulting services on data migration and systems integrations; training; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.

Company website ↗

VEEV Key Statistics

Previous Close$236.58P/E Ratio42.0
Market Cap$39.23BPEG Ratio1.06
Revenue (TTM)$3.32BROE13.93%
Gross Margin75.02%ROA7.30%
Debt / Equity1.4Employees7,928

VEEV in plain English

VEEV stock: frequently asked questions

What is Veeva Systems Inc.'s stock price today?

Veeva Systems Inc. (VEEV) last traded at $241.51 on the NYSE. Over the past 52 weeks the stock has traded between $148.05 and $310.50.

Is VEEV stock a buy or a sell?

Wall Street analysts' consensus rating on VEEV is "Buy", with an average 12-month price target of $244.14 — about +1.1% versus the current price of $241.51. Analyst targets are opinions, not guarantees; always do your own research.

How much would $1,000 invested in VEEV 10 years ago be worth today?

A $1,000 investment in Veeva Systems Inc. made 10 years ago would be worth about $5,902 today (dividends reinvested) — a total return of 490%, or 19.4% per year.

Does VEEV pay a dividend?

No — Veeva Systems Inc. does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.

What is VEEV's P/E ratio?

VEEV trades at a trailing price-to-earnings ratio of 42.0, and 24.1 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.

Do members of Congress trade VEEV stock?

Yes — 6 members of Congress have disclosed trades in VEEV under the STOCK Act, totaling 3 purchases and 5 sales worth an estimated $231,000.

What is Veeva Systems Inc.'s ticker symbol?

Veeva Systems Inc. trades under the ticker symbol VEEV on the NYSE.

Compare VEEV with peers

VEEV vs LLYEli Lilly and Company $1,220.28 VEEV vs JNJJohnson & Johnson $260.86 VEEV vs ABBVAbbVie Inc. $248.76 VEEV vs UNHUnitedHealth Group Incorporated $405.59 VEEV vs MRKMerck & Company, Inc. $132.92

Data last refreshed from public sources. Figures may be delayed. Not investment advice.